Navigation Links
Columbia geneticists uncover new gene involved in determining hair texture and density in humans

NEW YORK (Feb. 25, 2008) A Columbia University Medical Center research team has discovered a new gene involved in determining hair texture in humans. The team's genetic analysis demonstrated that mutations in a gene, known as P2RY5, cause hereditary "woolly hair" hair that is coarse, dry, tightly curled and sparse.

"Our findings indicate that mutations in the P2RY5 gene cause hereditary woolly hair. This is significant as it represents the discovery of the first new gene whose primary function seems to be the determination of hair texture in humans," said lead author Angela M. Christiano, Ph.D., the Richard and Mildred Rhodebeck Professor of Dermatology and Genetics & Development, at the Columbia University College of Physicians and Surgeons.

"This genetic finding may inform the development of new treatments for excessive or unwanted hair, or potentially hair growth." added Dr. Christiano.

Findings were published in an online edition of Nature Genetics at 1 p.m. EST on Sunday, February 24, 2008. The paper will appear in the journal's March print issue.

The genetic causes of hair texture in humans are largely unknown. Hair shafts emerge from the surface of the skin and display wide variability in texture and color among individuals of different populations around the world.

Since research has shown that woolly hair was common among Pakistani families, Dr. Christiano and her colleagues set out to determine why this type of hair was specific to this group of people. They hoped that finding the genetic basis of this unique type of hair would help them to distinguish other genetic hair types, and to learn more about the genetic underpinnings of different hair textures.

Much of Dr. Christiano's research has focused on dermatologic variants found in Pakistani families, as they often represent ideal subjects for genetic analyses as they tend to be relatively homogeneous, with close-knit families that tend to live nearby one another, and often intermarry.

To identify a gene involved in controlling hair texture, Dr. Christiano and her team performed a genetic analysis of six families of Pakistani origin, who all shared hereditary woolly hair. The cause of hereditary woolly hair was found to be a mutation in a gene called P2RY5. Until this discovery, the pathogenesis of hereditary woolly hair had been largely unknown.

As the authors write in the paper, "The bulb region of plucked hairs from woolly hair patients showed irregular bending without attachment of the root sheath." They propose that mutations in P2RY5 most likely result in hair follicle disruptions, which then compromise its anchoring to the hair shaft and cause the abnormal bending of the bulb region, leading to woolly hair.

Dr. Christiano's discoveries have led to the identification of several genes controlling human hair growth. It remains to be determined whether common variants on the P2RY5 gene can also contribute to naturally occurring variations in hair texture between different human populations.

According to the researchers, P2RY5 is the first gene of a type known as a G-protein coupled receptor (GPCR) implicated in a human hair disorder thereby making it possible to develop drugs that target this receptor. GPCRs represent the largest known class of molecular targets with proven therapeutic value. It is estimated that more than 40 percent of existing drugs work by targeting GPCR drug targets; this target class represents a large fraction of the total biological targets against which FDA-approved oral drugs are directed. Of the top 200 best-selling prescription drugs more than 20 percent interact with GPCRs, providing worldwide sales of over $20 billion.


Contact: Elizabeth Streich
Columbia University Medical Center

Related biology news :

1. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
2. 3 Columbia University Medical Center faculty elected to Institute of Medicine
3. Columbia researchers: Growth of CT scan use may lead to significant public health problem
4. Plant geneticists find veritas in vino
5. St. Jude influenza survey uncovers key differences between bird flu and human flu
6. 454 Sequencing uncovers a genetic basis for different social behaviors in wasp
7. Joslin researchers uncover potential role of leptin in diabetes
8. Agent that triggers immune response in plants is uncovered
9. UD plant biologists uncover top wetland plants hidden weapon
10. Massive microRNA scan uncovers leads to treating muscle degeneration
11. Scientists uncover how hormones achieve their effects
Post Your Comments:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
Breaking Biology Technology: